MiNK Therapeutics, Inc. (INKT) Free cash flow 2021–2024
MiNK Therapeutics, Inc. (INKT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.6MFY2024 · since FY2021: -$12.9M → -$9.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.6M | +39.9% |
| FY2023 | -$16.0M | +16.2% |
| FY2022 | -$19.1M | -47.9% |
| FY2021 | -$12.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice